Comparison of the effects of nefazodone and fluoxetine on sleep architecture and sleep efficiency in depressed patients

By Armitage R.   Yonkers K.   Rush A.J.   Cole D.   Novak K.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 299-299

Elsevier

Access to resources Recommend Favorite

Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline

By Kasper S.   Zivkov M.   Roes K.C.B.   Pols A.G.  

European Neuropsychopharmacology, Vol. 7, Iss. 2, 1997-05 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Changes in acute phase proteins in depressed patients, during treatment with fluoxetine and venlafaxine

By Sluzewska A.   Houml rning-Rohan M.   Sobieska M.   Rybakowski J.K.   Amsterdam J.D.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 295-296

Elsevier

Access to resources Recommend Favorite

Mirtazapine, fluoxetine comparable for severe depression

By  

Inpharma, Vol. 1, Iss. 1478, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Intravenous mirtazapine in the treatment of depressed inpatients

By Konstantinidis A.   Stastny J.   Ptak-Butta J.   Hilger E.   Winkler D.   Barnas C.   Neumeister A.   Kasper S.  

European Neuropsychopharmacology, Vol. 12, Iss. 1, 2002-02 ,pp. : 57-60

Elsevier

Access to resources Recommend Favorite